CRBP
Price
$9.00
Change
-$0.11 (-1.21%)
Updated
Aug 7 closing price
Capitalization
110.13M
XBIT
Price
$2.92
Change
+$0.02 (+0.69%)
Updated
Aug 7 closing price
Capitalization
89.02M
7 days until earnings call
Interact to see
Advertisement

CRBP vs XBIT

Header iconCRBP vs XBIT Comparison
Open Charts CRBP vs XBITBanner chart's image
Corbus Pharmaceuticals Holdings
Price$9.00
Change-$0.11 (-1.21%)
Volume$88.8K
Capitalization110.13M
XBiotech
Price$2.92
Change+$0.02 (+0.69%)
Volume$53.12K
Capitalization89.02M
CRBP vs XBIT Comparison Chart in %
Loading...
CRBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBP vs. XBIT commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBP is a Hold and XBIT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (CRBP: $9.00 vs. XBIT: $2.92)
Brand notoriety: CRBP and XBIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBP: 56% vs. XBIT: 50%
Market capitalization -- CRBP: $110.13M vs. XBIT: $89.02M
CRBP [@Biotechnology] is valued at $110.13M. XBIT’s [@Biotechnology] market capitalization is $89.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBP’s FA Score shows that 0 FA rating(s) are green whileXBIT’s FA Score has 1 green FA rating(s).

  • CRBP’s FA Score: 0 green, 5 red.
  • XBIT’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBP is a better buy in the long-term than XBIT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBP’s TA Score shows that 5 TA indicator(s) are bullish while XBIT’s TA Score has 5 bullish TA indicator(s).

  • CRBP’s TA Score: 5 bullish, 5 bearish.
  • XBIT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, XBIT is a better buy in the short-term than CRBP.

Price Growth

CRBP (@Biotechnology) experienced а -2.91% price change this week, while XBIT (@Biotechnology) price change was +0.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

XBIT is expected to report earnings on Aug 15, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBP($110M) has a higher market cap than XBIT($89M). CRBP YTD gains are higher at: -23.729 vs. XBIT (-26.076). XBIT has higher annual earnings (EBITDA): -36.99M vs. CRBP (-48.74M). XBIT has more cash in the bank: 156M vs. CRBP (133M). CRBP has less debt than XBIT: CRBP (2.86M) vs XBIT (10M). CRBP (0) and XBIT (0) have equivalent revenues.
CRBPXBITCRBP / XBIT
Capitalization110M89M124%
EBITDA-48.74M-36.99M132%
Gain YTD-23.729-26.07691%
P/E RatioN/AN/A-
Revenue00-
Total Cash133M156M85%
Total Debt2.86M10M29%
FUNDAMENTALS RATINGS
CRBP vs XBIT: Fundamental Ratings
CRBP
XBIT
OUTLOOK RATING
1..100
1614
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
74
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9796
PRICE GROWTH RATING
1..100
4663
P/E GROWTH RATING
1..100
1007
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRBP's Valuation (50) in the Biotechnology industry is in the same range as XBIT (74). This means that CRBP’s stock grew similarly to XBIT’s over the last 12 months.

CRBP's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as XBIT (100). This means that CRBP’s stock grew similarly to XBIT’s over the last 12 months.

XBIT's SMR Rating (96) in the Biotechnology industry is in the same range as CRBP (97). This means that XBIT’s stock grew similarly to CRBP’s over the last 12 months.

CRBP's Price Growth Rating (46) in the Biotechnology industry is in the same range as XBIT (63). This means that CRBP’s stock grew similarly to XBIT’s over the last 12 months.

XBIT's P/E Growth Rating (7) in the Biotechnology industry is significantly better than the same rating for CRBP (100). This means that XBIT’s stock grew significantly faster than CRBP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRBPXBIT
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
69%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
66%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 9 days ago
67%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 19 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
CRBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CBGZF0.290.02
+5.63%
Cabral Gold Inc.
JTEKF8.42N/A
N/A
JTEKT Corp.
PECGF0.86N/A
N/A
Petronas Chemicals Group Bhd
MSSUF10.05N/A
N/A
Metal Sky Star Acquisition Corporation
CBDBY0.52N/A
-0.71%
Companhia Brasileira de Distribuicao